Package 0904-6172-61

{"route": ["ORAL"], "spl_id": "4da43d38-dcd6-4447-8693-5e41e78aacbe", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "unii": ["33CM23913M"], "rxcui": ["308973", "308979"], "spl_set_id": ["2a8c7366-ce89-47ce-8123-96f26812fca0"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "2000 TABLET in 1 BOTTLE (0904-6172-50)", "package_ndc": "0904-6172-50", "marketing_start_date": "20100920"}, {"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0904-6172-61)  / 1 TABLET in 1 BLISTER PACK", "package_ndc": "0904-6172-61", "marketing_start_date": "20100920"}], "brand_name": "CARBAMAZEPINE", "product_id": "0904-6172_4da43d38-dcd6-4447-8693-5e41e78aacbe", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0904-6172", "generic_name": "CARBAMAZEPINE", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CARBAMAZEPINE", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "200 mg/1"}], "application_number": "ANDA077272", "marketing_category": "ANDA", "marketing_start_date": "20100920", "listing_expiration_date": "20271231"}